PHARM

Pharming Group NV (PHARM)

Pharming Group NV

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:EU:PHARM

1 2 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/03	15:00	GlobeNewswire Inc.	Pharming Group to participate in June investor conferences	EU:PHARM	Pharming Group NV
2024/06/03	15:00	GlobeNewswire Inc.	Pharming Group to participate in June investor conferences	EU:PHARM	Pharming Group NV
2024/05/31	05:44	GlobeNewswire Inc.	Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union	EU:PHARM	Pharming Group NV
2024/05/22	00:30	GlobeNewswire Inc.	Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders	EU:PHARM	Pharming Group NV
2024/05/22	00:30	GlobeNewswire Inc.	Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders	EU:PHARM	Pharming Group NV
2024/05/20	15:00	GlobeNewswire Inc.	Pharming Group to participate in May investor conference	EU:PHARM	Pharming Group NV
2024/05/20	15:00	GlobeNewswire Inc.	Pharming Group to participate in May investor conference	EU:PHARM	Pharming Group NV
2024/05/15	14:00	GlobeNewswire Inc.	Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025	EU:PHARM	Pharming Group NV
2024/05/08	14:00	GlobeNewswire Inc.	Pharming Group reports first quarter 2024 financial results and provides business update	EU:PHARM	Pharming Group NV
2024/05/08	14:00	GlobeNewswire Inc.	Pharming Group reports first quarter 2024 financial results and provides business update	EU:PHARM	Pharming Group NV
2024/04/24	15:00	GlobeNewswire Inc.	Pharming Group to report first quarter 2024 financial results on May 8	EU:PHARM	Pharming Group NV
2024/04/24	14:00	GlobeNewswire Inc.	Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards	EU:PHARM	Pharming Group NV
2024/04/24	14:00	GlobeNewswire Inc.	Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards	EU:PHARM	Pharming Group NV
2024/04/20	01:43	GlobeNewswire Inc.	Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025	EU:PHARM	Pharming Group NV
2024/04/18	22:04	GlobeNewswire Inc.	Pharming Group announces the placement of €100 million convertible bonds due 2029	EU:PHARM	Pharming Group NV
2024/04/18	15:00	GlobeNewswire Inc.	Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025	EU:PHARM	Pharming Group NV
2024/04/08	14:00	GlobeNewswire Inc.	Pharming announces completion of enrollment in pediatric clinical trial of leniolisib	EU:PHARM	Pharming Group NV
2024/04/08	14:00	GlobeNewswire Inc.	Pharming announces completion of enrollment in pediatric clinical trial of leniolisib	EU:PHARM	Pharming Group NV
2024/04/04	15:30	GlobeNewswire Inc.	Pharming Group announces the 2024 Annual General Meeting of Shareholders	EU:PHARM	Pharming Group NV
2024/04/04	14:00	GlobeNewswire Inc.	Pharming Group announces the filing of its 2023 Annual Report and Form 20-F	EU:PHARM	Pharming Group NV
2024/04/03	15:00	GlobeNewswire Inc.	Pharming Group to participate in April investor conferences	EU:PHARM	Pharming Group NV
2024/04/03	15:00	GlobeNewswire Inc.	Pharming Group to participate in April investor conferences	EU:PHARM	Pharming Group NV
2024/03/14	15:00	GlobeNewswire Inc.	Pharming Group reports fourth quarter and full year 2023 financial results	EU:PHARM	Pharming Group NV
2024/02/29	16:00	GlobeNewswire Inc.	Pharming Group to report fourth quarter and full year 2023 financial results on March 14	EU:PHARM	Pharming Group NV
2024/02/29	16:00	GlobeNewswire Inc.	Pharming Group to report fourth quarter and full year 2023 financial results on March 14	EU:PHARM	Pharming Group NV
2024/02/08	16:00	GlobeNewswire Inc.	Pharming Group to participate in February investor conferences	EU:PHARM	Pharming Group NV
2024/02/08	16:00	GlobeNewswire Inc.	Pharming Group to participate in February investor conferences	EU:PHARM	Pharming Group NV
2024/01/08	15:00	GlobeNewswire Inc.	Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update	EU:PHARM	Pharming Group NV
2024/01/08	15:00	GlobeNewswire Inc.	Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update	EU:PHARM	Pharming Group NV
2023/12/13	15:00	GlobeNewswire Inc.	Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)	EU:PHARM	Pharming Group NV